BridgeBio Neutral Stance From Citi Shakes ATTR-CM Outlook
Citi initiates BridgeBio at Neutral, signaling caution on ATTR-CM growth despite a strong near-term ramp. The move ad...
Planning for retirement? Learn what to include in your retirement checklist to ensure a secure and fulfilling future.
15,841 articlesCiti initiates BridgeBio at Neutral, signaling caution on ATTR-CM growth despite a strong near-term ramp. The move ad...
Bolt is reshaping its growth plan after a sweeping HR shakeup and large-scale layoffs. The fintech aims to regain spe...
Four giants could join the exclusive $3 trillion club by 2027. This article breaks down the drivers, the risks, and h...
Illinois regulators approve a sweeping regulatory framework for home equity investments, drawing praise from CHEP as ...
SpaceX’s IPO filing reveals Elon Musk’s proposed package, a historic grant that vests only if the company reaches a $...
As Wall Street eyes the next stock split, ASML, Lilly, and TransDigm sit near the top of the list. Analysts say the o...
The Cleveland Fed reports the five-year inflation outlook hasn’t been this high in 19 years, adding a new twist for i...
Regulators signal a push on Regulation X changes and a new GSE streamline refi pathway, as LO Comp revisions lose mom...
Two tech giants stand out for investors seeking value in megacap stocks. This guide breaks down strengths, risks, and...
AI-driven optimism pushes the S&P 500 to an eighth consecutive week of gains, led by big tech earnings and AI infrast...
Lionsgate delivered stronger-than-expected results, and its stock jumped. This article breaks down the key factors be...
A prominent fund dumped its monday.com stake in a move that coincided with a steep stock decline. This article breaks...